A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team.
about
Efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV infected children and adolescents: a systematic review and meta-analysisCo-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDSA combination drug of abacavir-lamivudine-zidovudine (Trizivir®) for treating HIV infection and AIDSSafety analysis of Ziagen® (abacavir sulfate) in postmarketing surveillance in JapanPENTA guidelines for the use of antiretroviral therapy in paediatric HIV infection. Pediatric European Network for Treatment of AIDS.SNPs--where's the beef?Diagnostic and management challenges for childhood tuberculosis in the era of HIV.Use of nucleoside reverse transcriptase inhibitor-only regimens in HIV-infected children and adolescents.Pharmacotherapy of pediatric and adolescent HIV infectionDisease Management - Constructing Optimal NRTI-Based Combinations: Past, Present, and Future.Safety of zidovudine/lamivudine scored tablets in children with HIV infection in Europe and Thailand.
P2860
Q21999480-6D2215F2-C567-4869-8F08-D8A887D6BE2BQ24200188-4EF3B5F6-077C-40B2-92B0-60C77D542144Q24239831-11319954-561D-48ED-A9A8-9B76805BC870Q34503521-1B3A0C7E-C591-4261-9096-4E739DBC7330Q34760550-104F0773-4691-4DC6-AC5E-253ECA820341Q35002542-A4B61E48-86A3-44BB-9088-ED9388C0FBACQ36877242-13DDA4C5-CDC1-453A-BA20-063C4EF98A79Q37154669-63A03D2E-74EB-4BA6-8181-534606AE704DQ37240305-84EF1ECB-CCF7-42EC-B664-D8CA56F60377Q37381677-E1F2EBA6-ED0C-415F-B4A6-6C84FE1CD468Q37699739-8BD68BDD-C08C-44DE-B8EC-8116022D89E5
P2860
A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
A randomized, double-blind stu ...... dren. The CNAA3006 Study Team.
@en
A randomized, double-blind stu ...... dren. The CNAA3006 Study Team.
@nl
type
label
A randomized, double-blind stu ...... dren. The CNAA3006 Study Team.
@en
A randomized, double-blind stu ...... dren. The CNAA3006 Study Team.
@nl
prefLabel
A randomized, double-blind stu ...... dren. The CNAA3006 Study Team.
@en
A randomized, double-blind stu ...... dren. The CNAA3006 Study Team.
@nl
P2093
P356
P1433
P1476
A randomized, double-blind stu ...... dren. The CNAA3006 Study Team.
@en
P2093
C G Richardson
C Mitchell
J A Church
J Sleasman
P Emmanuel
R P Nelson
R Van Dyke
S Hetherington
P356
10.1542/PEDS.107.1.E4
P407
P577
2001-01-01T00:00:00Z